山东凯盛新材料股份有限公司 关于控股股东非公开发行可交换公司债券换股进展暨权益变动比例 触及1%整数倍的公告

Core Viewpoint - The equity change is primarily due to the exchange of bonds by the bondholders of Huabang Health, resulting in a decrease in the controlling shareholder's stake from 32.49% to 31.68%, which touches the 1% integer multiple threshold [1][5]. Group 1: Equity Change Details - Huabang Health issued non-public exchangeable bonds with a total scale of 600 million yuan, with an initial conversion price of 14.88 yuan per share, adjusted to 14.83 yuan per share after the 2024 annual equity distribution [1]. - The exchange period for the bonds began on October 23, 2025, and will last until April 21, 2028, allowing bondholders to convert their bonds into company shares [2]. - From October 23 to October 27, 2025, bondholders exchanged a total of 21,186,747 shares, reducing Huabang Health's stake from 39.75% to 34.72% [2]. - On October 28, 2025, an additional 4,369,515 shares were exchanged, further reducing Huabang Health's stake to 33.68% [3]. - Between October 29 and October 30, 2025, bondholders exchanged 4,973,021 shares, bringing Huabang Health's stake down to 32.49% [3]. - On November 3, 2025, the final exchange of 3,425,485 shares was reported, resulting in a decrease of Huabang Health's stake to 31.68% [3]. Group 2: Regulatory Compliance and Impact - The equity change does not trigger a mandatory tender offer and will not lead to changes in the controlling shareholder or actual controller, nor will it significantly impact the company's governance structure or ongoing operations [1][5]. - All shares involved in the equity change retain voting rights, and there are no restrictions on the transfer of these shares [5]. - The company will continue to monitor the exchange situation and fulfill its information disclosure obligations as required by relevant laws and regulations [5].